Literature DB >> 1676446

Stevens-Johnson syndrome after fluconazole.

M J Gussenhoven, A Haak, J D Peereboom-Wynia, J W van 't Wout.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1676446     DOI： 10.1016/0140-6736(91)90112-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

Review 2.  Antifungal therapy for newborn infants with invasive fungal infection.

Authors:  Linda Clerihew; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

Review 3.  Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.

Authors:  Jemma Cleminson; Nicola Austin; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2015-10-24

Review 4.  Toxic epidermal necrolysis in a neonate receiving fluconazole.

Authors:  S Islam; M Singer; J A Kulhanjian
Journal:  J Perinatol       Date:  2014-10       Impact factor: 2.521

Review 5.  Fluconazole. An update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis.

Authors:  C M Perry; R Whittington; D McTavish
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

6.  Skin rash in the intensive care unit: Stevens-Johnson syndrome, toxic epidermal necrolysis, or a rare manifestation of a hidden cutaneous malignancy: A case report.

Authors:  Farah Al-Saffar; Saif Ibrahim; Pujan Patel; Rafik Jacob; Carlos Palacio; James Cury
Journal:  Mol Clin Oncol       Date:  2015-12-16

Review 7.  Adverse effects of drugs used in the management of opportunistic infections associated with HIV infection.

Authors:  B S Peters; E Carlin; R J Weston; S J Loveless; J Sweeney; J Weber; J Main
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 8.  Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.

Authors:  K L Goa; L B Barradell
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

9.  Potent Synergy between Spirocyclic Pyrrolidinoindolinones and Fluconazole against Candida albicans.

Authors:  Ilandari Dewage Udara Anulal Premachandra; Kevin A Scott; Chengtian Shen; Fuqiang Wang; Shelley Lane; Haoping Liu; David L Van Vranken
Journal:  ChemMedChem       Date:  2015-08-12       Impact factor: 3.466

10.  Fluconazole induced toxic epidermal necrolysis: a case report.

Authors:  Uchenna R Ofoma; Edward K Chapnick
Journal:  Cases J       Date:  2009-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.